Urgo Sp. z o.o. has acquired 100% of MyBestPharm S.A., a leading Polish brand in dietary supplements and dermocosmetics, with plans to accelerate growth in both domestic and international markets.
Target Information
Saski Partners, a division of Corporate Finance International, acted as the exclusive financial advisor for the shareholder of MyBestPharm S.A. in the sale of 100% of its shares to Urgo Sp. z o.o.
Established in 2021, MyBestPharm S.A. is a leading Polish brand renowned for its high-quality dietary supplements, functional foods, and dermocosmetics. Within just four years, the company has developed a robust product portfolio characterized by advanced formulations, high concentrations of active ingredients, and stringent testing protocols. Bestsellers include MyBestBeauty+, MyBestProtect, and MyBestComplement. With the support of Urgo Healthcare, MyBestPharm aims to accelerate its growth in Poland and expand into international markets, targeting to double its revenue by 2030.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview in Poland
The dietary supplements and wellness market in Poland has experienced significant growth in recent years, driven by an increasing consumer focus on health and wellness. This
Similar Deals
Polmed S.A. → Kliniki Neuroradiochirurgii
2024
Urgo Sp. z o. o.
invested in
MyBestPharm S.A.
in 2025
in a Other deal